Seremedi Selected as a Resident Company at JLABS @ TMC

HOUSTON, TX--(Marketwired - Mar 9, 2016) - Seremedi is pleased to announce that it has been selected to be one of the inaugural resident companies at Johnson & Johnson Innovation, JLABS (JLABS) newest location JLABS @ TMC. JLABS recently expanded their presence to the Texas Medical Center (TMC) in Houston, the largest medical center in the world, and accepted Seremedi as a resident company to help measure and grow the benefits of Seremedi's CareScriptions platform. 

The CareScriptions platform consolidates care pathway information into one location so a patient undergoing a surgical procedure knows what to expect and what is expected of them throughout the episode. It is the only product on the market that guides patients through the entire surgical continuum of care, from the moment the surgery is scheduled, while the patient is recovering in the hospital, and as the patient recovers remotely, to make 100 percent recovery the standard of care.

The platform delivers customized care pathways through its mobile technology so the patient has continual access to care instructions and stays connected to the care team every step of the way. This minimizes adverse events, reduces readmission rates, improves hospital efficiency, enhances patient recovery and improves patient experience following surgery. 

"We are thrilled to be part of the JLABS @ TMC community and are already benefitting from our relationship," said Kim Bond Evans, Founder and CEO of Seremedi. "We are gaining traction with several of the renowned TMC institutions and are strengthening our foundation for expansion."

Seremedi is also returning to SXSW Interactive in 2016 as an exhibitor at the SX Health & MedTech Expo March 12 and 13 at the JW Marriott in Austin, TX and can be found at booth 24.

About Seremedi
Seremedi is a digital healthcare company headquartered in Houston, Texas. We are a team of accomplished clinicians, security experts, data and medical informatics scientists with proven experience in delivering secure, scalable commercial software that delights customers. More importantly, we are patients and caregivers, who work everyday to enable surgical teams make 100 percent recovery the standard of care.

CareScriptions® was developed in collaboration with a multidisciplinary team of clinical surgeons, investigators and educators committed to enhancing the quality of care afforded patients undergoing major operations. We are a resident company at JLABS @ TMC and delighted to be part of the Texas Medical Center's tradition of delivering innovative solutions to the global community.